B-cell enrichment predictive of immunotherapy response in melanoma, sarcoma and kidney cancer

[D.ap]

“The likelihood of a patient responding to immune checkpoint blockade may depend on B cells in the tumor, located within specialized immune-cell clusters known as tertiary lymphoid structures (TLS), according to researchers at The University of Texas MD Anderson Cancer Center.”

Mhttps://www.sciencedaily.com/releases/2020/01/200115132624.htm